YV BioMedconsult SRL
YV BioMedconsult reported total assets of 82,524 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 May 2026).
The score of YV BioMedconsult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -77 % Total assets -48 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
YV BioMedconsult's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 May 2026
- Year ended 31 Dec 2024filed on 25 Apr 2025
- Year ended 31 Dec 2023filed on 16 Feb 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
YV BioMedconsult's financial analysis
- Solvency41.6%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of YV BioMedconsult
YV BioMedconsult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0751.734.855
- VAT number
- BE0751734855
- Peppol
- Registered · 0208:0751734855 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Aug 2020
- Registered office
- 1933 Zaventem
- Latest accounts
- 2025 · filed on 18 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
YV BioMedconsult (SRL) has been based in Zaventem since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 29,356 € and equity of 34,356 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to YV BioMedconsult
Companies in the same business, of comparable size and area, outside its group.
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- ADBDL Médecine et Sciences médicales Research and experimental development on natural sciences and engineering Wavre · balance sheet 85,668 €
- Novocure Belgium Research and experimental development on natural sciences and engineering Saint-Josse-ten-Noode · balance sheet 85,983 €
- Docteur Paolo Battisti Research and experimental development on natural sciences and engineering Clavier · balance sheet 86,909 €
- Zaience Research and experimental development on natural sciences and engineering Boom · balance sheet 81,571 €
- PDVT Research and experimental development on natural sciences and engineering Molenbeek-Saint-Jean · balance sheet 91,865 €
- Consultomics Research and experimental development on natural sciences and engineering Leuven · balance sheet 73,481 €
Frequently asked questions about YV BioMedconsult
What is the revenue of YV BioMedconsult?
YV BioMedconsult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of YV BioMedconsult?
In Belgium, the VAT number is the company number prefixed with BE: BE0751734855 for YV BioMedconsult, if the company is VAT-registered. Its company number (CBE) is 0751.734.855.
Where is the registered office of YV BioMedconsult?
According to the CBE register, the registered office of YV BioMedconsult is in 1933 Zaventem.
What is the equity of YV BioMedconsult?
At the close of the 2025 financial year, the equity of YV BioMedconsult amounts to 34,356 €, a solvency of 41.6% of total assets.
Who manages YV BioMedconsult?
The register lists 1 active mandates at YV BioMedconsult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of YV BioMedconsult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →